Metformin Hydrochloride + Sitagliptin
Composition
The formulation contains Sitagliptin & Metformin Hydrochloride as the active ingredient.
Indications
Type 2 diabetes mellitus
Side effects
Hypoglycemia, GI upset, headache
Precautions
Monitor renal function regularly. Use caution in patients with hepatic impairment.
Contraindications
Hypersensitivity to Metformin, Sitagliptin, or any component, severe renal impairment, diabetic ketoacidosis.
Dosage and administration
As directed by healthcare provider
Countries
Worldwide
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai